- Home
- OSRHW vs EICA Comparison
OSRHW vs EICA Comparison
Compare OSRHW & EICA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | OSRHW | EICA |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | |
| Employees | 21 | N/A |
| Industry | | Finance/Investors Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OSRHW | EICA |
|---|---|---|
| Price | $0.06 | $24.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | N/A |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | N/A | N/A |
| 52 Week High | N/A | N/A |
Technical Indicators
Market Signals| Indicator | OSRHW | EICA |
|---|---|---|
| Relative Strength Index (RSI) | 57.21 | 63.06 |
| Support Level | $0.05 | $24.63 |
| Resistance Level | $0.06 | $24.75 |
| Average True Range (ATR) | 0.00 | 0.06 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 93.87 | 75.00 |
Price Performance
Historical ComparisonAbout OSRHW OSR Holdings Inc. Warrant
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
About EICA Eagle Point Income Company Inc. 5.00% Series A Term Preferred Stock due 2026
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.